Acute toxicity hypofractionated-IMRT vs standard radiotherapy in prostate cancer: comparative study

被引：0
|
作者：
Valero Albarran, J. [1 ]
Domingos da Silva, R. Guimaraes [2 ]
Payano, S. [1 ]
Montero, A. [1 ]
Sanchez, E. [1 ]
Chen, X. [1 ]
Hernando, O. [1 ]
Garcia Aranda, M. [1 ]
Ciervide, R. [1 ]
Lopez, M. [1 ]
Rubio, M. [1 ]
机构：
[1] Hosp Univ HM Sanchinarro, Radiat Oncol, Madrid, Spain
[2] Inst Natl Canc, Oncol Radiat, Rio De Janeiro, Brazil
来源：
RADIOTHERAPY AND ONCOLOGY | 2016年 / 119卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP-1384
引用
收藏
页码：S646 / S646
页数：1
相关论文
共 50 条
  • [31] A dosimetric feasibility study of conformal radiotherapy (CRT) vs. intensity modulated radiotherapy (IMRT) vs. simultaneously integrated hypofractionated boost IMRT (SIHB) in prostate adenocarcinoma.
    Karvat, A
    Yu, C
    Liu, M
    Kristensen, S
    Kalach, N
    RADIOTHERAPY AND ONCOLOGY, 2004, 72 : S55 - S56
  • [32] Hypofractionated radiotherapy for prostate cancer
    Teh, Bin S.
    Ishiyama, Hiromichi
    LANCET ONCOLOGY, 2012, 13 (01): : 5 - 6
  • [33] Hypofractionated IMRT With Simultaneous Integrated Boost for High-risk Prostate Cancer Patients: Acute Toxicity Report
    Lecavalier-Barsoum, M.
    Faria, S.
    Ruo, R.
    Cury, F.
    David, M.
    Duclos, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S364 - S364
  • [34] Hypofractionated radiotherapy in prostate cancer
    Supiot, S.
    Crehange, G.
    Latorzeff, I.
    Pommier, P.
    Paumier, A.
    Rio, E.
    Delaroche, G.
    Guerif, S.
    Catton, C.
    Martin, J.
    Lisbona, A.
    CANCER RADIOTHERAPIE, 2013, 17 (5-6): : 349 - 354
  • [35] Hypofractionated radiotherapy for prostate cancer
    Hegemann, Nina-Sophie
    Guckenberger, Matthias
    Belka, Claus
    Ganswindt, Ute
    Manapov, Farkhad
    Li, Minglun
    RADIATION ONCOLOGY, 2014, 9
  • [36] Hypofractionated radiotherapy for prostate cancer
    Nina-Sophie Hegemann
    Matthias Guckenberger
    Claus Belka
    Ute Ganswindt
    Farkhad Manapov
    Minglun Li
    Radiation Oncology, 9
  • [37] Hypofractionated radiotherapy in prostate cancer
    Dearnaley, David P.
    LANCET ONCOLOGY, 2015, 16 (03): : 237 - 238
  • [38] Hypofractionated radiotherapy for prostate cancer
    Dearnaley, David
    Hall, Emma
    LANCET ONCOLOGY, 2016, 17 (12): : E518 - E518
  • [39] Dose Escalation Study with Two Different Hypofractionated Intensity Modulated Radiotherapy Techniques for Localized Prostate Cancer: Acute Toxicity
    Zilli, Thomas
    Rouzaud, Michel
    Jorcano, Sandra
    Dipasquale, Giovanna
    Nouet, Philippe
    Ignacio Toscas, Jose
    Casanova, Nathalie
    Wang, Hui
    Escude, Lluis
    Molla, Meritxell
    Linero, Dolors
    Weber, Damien C.
    Miralbell, Raymond
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2010, 9 (03) : 263 - 270
  • [40] Phase II study of hypofractionated radiotherapy (HYPORT) in localised prostate cancer: Report on acute and 18 month late toxicity
    Garcia-Rojo, Dario
    Macias, Victor
    Gonzalez, Jose L.
    Gallardo, Enrique
    Prera, Angel
    Abad, Carlos
    Vicente, Eduardo
    Hannaoui, Naim
    Martos, Raul
    Ropero, Jordi
    Prats, Juan
    JOURNAL OF UROLOGY, 2008, 179 (04): : 397 - 398
12345